Lexeo Therapeutics, Inc.

LXEO

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001907108

SEC filings (opens in a new tab)

In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Lexeo Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of LXEO: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Q4 2024	Change
Holders	69	90	+21
Shares	29.7M	29.5M	−216.0K (−0.7%)
Value	$268.8M	$194.2M	−$74.6M (−27.8%)

New holders (29)

Institutions that held Lexeo Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to LXEO in Q4 2024
Institution	Shares	Value	% of portfolio
Altium Capital Management LP	405,000	$2.66M	0.83%
Privium Fund Management B.V.	138,115	$908.8K	0.21%
Opaleye Management Inc.	130,000	$855.4K	0.15%
Bridgeway Capital Management, LLC	65,000	$427.7K	0.01%
Walleye Capital LLC	61,930	$407.5K	0.00%
Superstring Capital Management LP	52,616	$346.2K	0.30%
Aristides Capital LLC	29,285	$192.7K	0.06%
Jump Financial, LLC	20,400	$134.2K	0.00%
Marshall Wace, LLP	17,794	$117.1K	0.00%
Pale Fire Capital SE	16,100	$105.9K	0.02%
Corton Capital Inc.	13,771	$90.6K	0.05%
Intech Investment Management LLC	11,565	$76.1K	0.00%
Susquehanna International Group, LLP	11,148	$73.4K	0.00%
SG Americas Securities, LLC	10,960	$72.0K	0.00%
AQR Capital Management LLC	10,710	$70.5K	0.00%
Price T Rowe Associates Inc	10,425	$69.0K	0.00%
China Universal Asset Management Co., Ltd.	7,011	$46.1K	0.00%
Police & Firemen's Retirement System of New Jersey	6,040	$39.7K	0.00%
Allostery Investments LP	5,054	$33.3K	0.07%
Cubist Systematic Strategies, LLC	1,726	$11.4K	0.00%
Skopos Labs, Inc.	1,465	$9.64K	0.00%
Mirae Asset Global Investments Co., Ltd.	1,102	$7.47K	0.00%
GF Fund Management Co. Ltd.	694	$4.57K	0.00%
Russell Investments Group, Ltd.	416	$2.74K	0.00%
Nisa Investment Advisors, LLC	396	$2.61K	0.00%
GAMMA Investing LLC	245	$1.61K	0.00%
SBI Securities Co., Ltd.	197	$1.30K	0.00%
Rothschild Investment LLC	20	$132	0.00%
IFP Advisors, Inc	6	$39	0.00%

Sold out (8)

Institutions that held Lexeo Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of LXEO in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Braidwell LP	728,777	$6.59M
Exome Asset Management LLC	88,148	$796.9K
Polar Asset Management Partners Inc.	59,800	$540.6K
Prelude Capital Management, LLC	30,725	$277.8K
Jacobs Levy Equity Management, Inc	30,346	$274.3K
PDT Partners, LLC	26,608	$240.5K
Values First Advisors, Inc.	7,446	$67.3K
SRS Capital Advisors, Inc.	12	$109